Galena Biopharma, Inc.
(NASDAQ : GALE)

( )
GALE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading GALE News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.36%167.451.2%$748.20m
INCYIncyte Corporation
0.39%141.281.7%$605.33m
GILDGilead Sciences, Inc.
0.13%67.831.0%$601.46m
CELGCelgene Corporation
-0.36%123.371.0%$514.89m
BIIBBiogen Inc.
0.75%277.871.3%$450.36m
REGNRegeneron Pharmaceuticals, Inc.
-0.50%369.142.1%$315.18m
ALXNAlexion Pharmaceuticals, Inc.
1.16%120.081.6%$211.26m
KITEKite Pharma, Inc.
-0.38%76.3818.8%$203.08m
TSROTESARO, Inc.
4.08%155.7816.1%$174.37m
ILMNIllumina, Inc.
2.62%167.793.7%$163.14m
ESPREsperion Therapeutics, Inc.
-0.10%39.0118.7%$159.25m
AUPHAurinia Pharmaceuticals Inc.
1.91%8.536.3%$142.55m
CLVSClovis Oncology, Inc.
3.99%67.1817.5%$139.83m
VRTXVertex Pharmaceuticals Incorporated
0.60%90.042.2%$135.42m
EXELExelixis, Inc.
0.20%20.487.0%$105.01m

Company Profile

Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.